Alessandra Calabrese

Naples, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

CDK4/6i in the Underrepresented Histological Subtypes of HR±/HER2- Metastatic Breast Cancer: A Real-World Cohort Study of Effectiveness and Safety.

CDK4/6i in the Underrepresented Histological Subtypes of HR±/HER2- Metastatic Breast Cancer: A Real-World Cohort Study of Effectiveness and Safety.

Journal: Clinical breast cancer
Published: April 22, 2026

Predictive genomic medicine enlarges the spectrum of predisposing mutations for head and neck cancers via a panel of 56 genes selected for human neoplasia in Southern Italy: a pilot study.

Predictive genomic medicine enlarges the spectrum of predisposing mutations for head and neck cancers via a panel of 56 genes selected for human neoplasia in Southern Italy: a pilot study.

Journal: Clinical chemistry and laboratory medicine
Published: September 03, 2025

Caprine herpes virus-1 reduces cell viability and enhances chemosensitivity in breast cancer cells.

Caprine herpes virus-1 reduces cell viability and enhances chemosensitivity in breast cancer cells.

Journal: Frontiers in oncology
Published: July 30, 2025

CAR-T cell therapy for breast cancer: Current status and future perspective.

CAR-T cell therapy for breast cancer: Current status and future perspective.

Journal: Cancer treatment reviews
Published: October 29, 2024

The multidisciplinary management of HER2-positive breast cancer brain metastases: from new biological insights to future therapeutic options.

The multidisciplinary management of HER2-positive breast cancer brain metastases: from new biological insights to future therapeutic options.

Journal: Frontiers in oncology
Published: June 11, 2024

Pharmacological inhibition of CDK4/6 impairs diffuse pleural mesothelioma 3D spheroid growth and reduces viability of cisplatin-resistant cells.

Pharmacological inhibition of CDK4/6 impairs diffuse pleural mesothelioma 3D spheroid growth and reduces viability of cisplatin-resistant cells.

Journal: Frontiers in oncology
Published: April 17, 2024

Prevention, diagnosis and clinical management of hereditary breast cancer beyond BRCA1/2 genes.

Prevention, diagnosis and clinical management of hereditary breast cancer beyond BRCA1/2 genes.

Journal: Cancer treatment reviews
Published: February 06, 2024

Cancer genetic counselling for hereditary breast cancer in the era of precision oncology.

Cancer genetic counselling for hereditary breast cancer in the era of precision oncology.

Journal: Cancer treatment reviews
Published: December 30, 2023

Predictive medicine in a testis trio-family through a combined multi-omics approach.

Predictive medicine in a testis trio-family through a combined multi-omics approach.

Journal: Clinical and translational medicine
Published: November 27, 2023

Central obesity, body mass index, metabolic syndrome and mortality in Mediterranean breast cancer patients.

Central obesity, body mass index, metabolic syndrome and mortality in Mediterranean breast cancer patients.

Journal: Scientific reports
Published: August 22, 2023

Multi-gene panel testing increases germline predisposing mutations' detection in a cohort of breast/ovarian cancer patients from Southern Italy.

Multi-gene panel testing increases germline predisposing mutations' detection in a cohort of breast/ovarian cancer patients from Southern Italy.

Journal: Frontiers in medicine
Published: March 11, 2022

Microbiome composition indicate dysbiosis and lower richness in tumor breast tissues compared to healthy adjacent paired tissue, within the same women.

Microbiome composition indicate dysbiosis and lower richness in tumor breast tissues compared to healthy adjacent paired tissue, within the same women.

Journal: BMC cancer
Published: July 12, 2021
Showing 1-12 of 16

Last Updated: 09/26/2026